Literature DB >> 30976948

Theranostics: is it really a revolution? Evaluating a new term in medicine.

Urban Wiesing1.   

Abstract

Theranostics or theragnostics are new terms which start to appear occasionally in publications from 2001 onwards, with a marked increase in references from 2011. In the last few years more than 1100 articles using this term were published each year. In 2011 the journal Theranostics was founded. This paper addresses the question of whether this new term is appropriate. The etymology of the term is analysed. A literature search for definitions of "theranostics" is carried out and the definitions examined as to whether they give grounds for justifying the use of a new term. The differences between diagnostics and therapy are explored. A broad and a narrow definition are found. According to the broad definition theranostics provides a closer relationship between diagnostics and therapy. According to the narrow definition diagnostics and therapy become a single intervention. On closer examination it turns out that in the narrow definition the diagnostics capacities are limited to monitoring. Neither the broad nor the narrow definition actually demonstrate a new concept in medicine. Rather, they describe the well-known practice of medical decision making. In this respect, the new term cannot be justified. The level of diagnostics is new (molecular/nano) but not the relationship between diagnostics and therapy. The term theranostics is misleading as it obscures the existing differences between diagnostics and therapy and wrongly insinuates that steps between diagnostics and therapy could be omitted.

Keywords:  Diagnostic; Theory of medicine; Theranostics; Therapy

Mesh:

Year:  2019        PMID: 30976948     DOI: 10.1007/s11019-019-09898-3

Source DB:  PubMed          Journal:  Med Health Care Philos        ISSN: 1386-7423


  17 in total

Review 1.  Next revolution in molecular theranostics: personalized medicine for urologic cancers.

Authors:  Fouad Aoun; Hampig Raphael Kourie; Carlos Artigas; Thierry Roumeguère
Journal:  Future Oncol       Date:  2015       Impact factor: 3.404

Review 2.  Theranostics: combining imaging and therapy.

Authors:  Sneha S Kelkar; Theresa M Reineke
Journal:  Bioconjug Chem       Date:  2011-08-29       Impact factor: 4.774

3.  Precision medicine and molecular imaging: new targeted approaches toward cancer therapeutic and diagnosis.

Authors:  Mojtaba Ghasemi; Iraj Nabipour; Abdolmajid Omrani; Zeinab Alipour; Majid Assadi
Journal:  Am J Nucl Med Mol Imaging       Date:  2016-11-30

4.  A New Theranostic Paradigm for Advanced Thyroid Cancer.

Authors:  David A Pattison; Benjamin Solomon; Rodney J Hicks
Journal:  J Nucl Med       Date:  2016-03-31       Impact factor: 10.057

Review 5.  [Gene therapy and immunotherapy in prostatic carcinoma].

Authors:  U Fiedler; M P Wirth
Journal:  Urologe A       Date:  2001-05       Impact factor: 0.639

6.  From art to science: a new epistemological status for medicine? On expectations regarding personalized medicine.

Authors:  Urban Wiesing
Journal:  Med Health Care Philos       Date:  2018-12

Review 7.  Theranostic lipid nanoparticles for cancer medicine.

Authors:  Danielle M Charron; Juan Chen; Gang Zheng
Journal:  Cancer Treat Res       Date:  2015

Review 8.  Personalized Medicine Based on Theranostic Radioiodine Molecular Imaging for Differentiated Thyroid Cancer.

Authors:  Byeong-Cheol Ahn
Journal:  Biomed Res Int       Date:  2016-04-28       Impact factor: 3.411

Review 9.  Theranostics: A treasured tailor for tomorrow.

Authors:  S Jeelani; R C Jagat Reddy; Thangadurai Maheswaran; G S Asokan; A Dany; B Anand
Journal:  J Pharm Bioallied Sci       Date:  2014-07

10.  Multidisciplinary efforts driving translational theranostics.

Authors:  Tony Y Hu
Journal:  Theranostics       Date:  2014-09-19       Impact factor: 11.556

View more
  4 in total

Review 1.  The Combination of Solid-State Chemistry and Medicinal Chemistry as the Basis for the Synthesis of Theranostics Platforms.

Authors:  Dmitry Korolev; Viktor Postnov; Ilia Aleksandrov; Igor Murin
Journal:  Biomolecules       Date:  2021-10-19

Review 2.  Targeted Drug Delivery and Theranostic Strategies in Malignant Lymphomas.

Authors:  Tomas Etrych; Alena Braunova; David Zogala; Lukas Lambert; Nicol Renesova; Pavel Klener
Journal:  Cancers (Basel)       Date:  2022-01-26       Impact factor: 6.639

3.  The Evolution of Targeted Radionuclide Diagnosis of HER2-Positive Breast Cancer.

Authors:  O D Bragina; S M Deyev; V I Chernov; V M Tolmachev
Journal:  Acta Naturae       Date:  2022 Apr-Jun       Impact factor: 2.204

4.  Advances in the Field of Micro- and Nanotechnologies Applied to Extracellular Vesicle Research: Take-Home Message from ISEV2021.

Authors:  Silvia Picciolini; Francesca Rodà; Marzia Bedoni; Alice Gualerzi
Journal:  Micromachines (Basel)       Date:  2021-12-16       Impact factor: 2.891

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.